My NCBISign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 364

    1.

    Maintenance treatment with esomeprazole following initial relief of non-steroidal anti-inflammatory drug-associated upper gastrointestinal symptoms: the NASA2 and SPACE2 studies.

    Hawkey CJ, Talley NJ, Scheiman JM, Jones RH, Långström G, Naesdal J, Yeomans ND; NASA/SPACE author group.

    Arthritis Res Ther. 2007;9(1):R17.PMID: 17391505 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Improvements with esomeprazole in patients with upper gastrointestinal symptoms taking non-steroidal antiinflammatory drugs, including selective COX-2 inhibitors.

    Hawkey C, Talley NJ, Yeomans ND, Jones R, Sung JJ, Långström G, Naesdal J, Scheiman JM; NASA1 SPACE1 Study Group.

    Am J Gastroenterol. 2005 May;100(5):1028-36.PMID: 15842575 [PubMed - indexed for MEDLINE]Related articles

    3.

    Esomeprazole for the management of upper gastrointestinal symptoms in patients who require NSAIDs: a review of the NASA and SPACE double-blind, placebo-controlled studies.

    Hawkey CJ, Svedberg LE, Naesdal J, Byrne C.

    Clin Drug Investig. 2009;29(10):677-87. doi: 10.2165/11317830-000000000-00000.PMID: 19715384 [PubMed - indexed for MEDLINE]Related articles

    4.

    Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors.

    Scheiman JM, Yeomans ND, Talley NJ, Vakil N, Chan FK, Tulassay Z, Rainoldi JL, Szczepanski L, Ung KA, Kleczkowski D, Ahlbom H, Naesdal J, Hawkey C.

    Am J Gastroenterol. 2006 Apr;101(4):701-10. Epub 2006 Feb 22.PMID: 16494585 [PubMed - indexed for MEDLINE]Related articles

    5.

    Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trial.

    Chan FK, Wong VW, Suen BY, Wu JC, Ching JY, Hung LC, Hui AJ, Leung VK, Lee VW, Lai LH, Wong GL, Chow DK, To KF, Leung WK, Chiu PW, Lee YT, Lau JY, Chan HL, Ng EK, Sung JJ.

    Lancet. 2007 May 12;369(9573):1621-6.PMID: 17499604 [PubMed - indexed for MEDLINE]Related articles

    6.

    Efficacy of esomeprazole (20 mg once daily) for reducing the risk of gastroduodenal ulcers associated with continuous use of low-dose aspirin.

    Yeomans N, Lanas A, Labenz J, van Zanten SV, van Rensburg C, Rácz I, Tchernev K, Karamanolis D, Roda E, Hawkey C, Nauclér E, Svedberg LE.

    Am J Gastroenterol. 2008 Oct;103(10):2465-73. Epub 2008 Jul 12.PMID: 18637091 [PubMed - indexed for MEDLINE]Related articles

    7.

    Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation.

    Chen YF, Jobanputra P, Barton P, Bryan S, Fry-Smith A, Harris G, Taylor RS.

    Health Technol Assess. 2008 Apr;12(11):1-278, iii. Review.PMID: 18405470 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Efficacy of esomeprazole for resolution of symptoms of heartburn and acid regurgitation in continuous users of non-steroidal anti-inflammatory drugs.

    Hawkey CJ, Jones RH, Yeomans ND, Scheiman JM, Talley NJ, Goldstein JL, Ahlbom H, Naesdal J.

    Aliment Pharmacol Ther. 2007 Apr 1;25(7):813-21.PMID: 17373920 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Treatment of endoscopy-negative NSAID-induced upper gastrointestinal symptoms with cimetidine: an international multicentre collaborative study.

    Bijlsma JW.

    Aliment Pharmacol Ther. 1988;2 Suppl 1:75-83.PMID: 2979286 [PubMed - indexed for MEDLINE]Related articles

    10.

    Intragastric acid control in non-steroidal anti-inflammatory drug users: comparison of esomeprazole, lansoprazole and pantoprazole.

    Goldstein JL, Miner PB Jr, Schlesinger PK, Liu S, Silberg DG.

    Aliment Pharmacol Ther. 2006 Apr 15;23(8):1189-96.PMID: 16611280 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Esomeprazole 40 mg once a day in patients with functional dyspepsia: the randomized, placebo-controlled "ENTER" trial.

    van Zanten SV, Armstrong D, Chiba N, Flook N, White RJ, Chakraborty B, Gasco A.

    Am J Gastroenterol. 2006 Sep;101(9):2096-106. Epub 2006 Jun 30. Erratum in: Am J Gastroenterol. 2006 Sep;101(9):2171. PMID: 16817845 [PubMed - indexed for MEDLINE]Related articles

    12.

    Efficacy and tolerability of pantoprazole compared with misoprostol for the prevention of NSAID-related gastrointestinal lesions and symptoms in rheumatic patients.

    Stupnicki T, Dietrich K, González-Carro P, Straszak A, Terjung A, Thomas KB, Lühmann R, Fischer R.

    Digestion. 2003;68(4):198-208. Epub 2003 Dec 30.PMID: 14707396 [PubMed - indexed for MEDLINE]Related articles

    13.

    Upper gastrointestinal tract safety of daily oral risedronate in patients taking NSAIDs: a randomized, double-blind, placebo-controlled trial.

    Adami S, Pavelka K, Cline GA, Hosterman MA, Barton IP, Cohen SB, Bensen WG.

    Mayo Clin Proc. 2005 Oct;80(10):1278-85.PMID: 16212139 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Upper gastrointestinal tolerability of once weekly alendronate 70 mg with concomitant non-steroidal anti-inflammatory drug use.

    Cryer B, Miller P, Petruschke RA, Chen E, Geba GP, Papp AE.

    Aliment Pharmacol Ther. 2005 Mar 1;21(5):599-607.PMID: 15740544 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Prevention of NSAID-associated gastrointestinal lesions: a comparison study pantoprazole versus omeprazole.

    Regula J, Butruk E, Dekkers CP, de Boer SY, Raps D, Simon L, Terjung A, Thomas KB, Lühmann R, Fischer R.

    Am J Gastroenterol. 2006 Aug;101(8):1747-55. Epub 2006 Jun 30.PMID: 16817839 [PubMed - indexed for MEDLINE]Related articles

    16.

    Low frequency of upper gastrointestinal complications in a cohort of high-risk patients taking low-dose aspirin or NSAIDS and omeprazole.

    Lanas A, Rodrigo L, Márquez JL, Bajador E, Pérez-Roldan F, Cabrol J, Quintero E, Montoro M, Gomollón F, Santolaria S, Lorente S, Cucala M, Nuevo J; EMPHASYS Study Group.

    Scand J Gastroenterol. 2003 Jul;38(7):693-700.PMID: 12889553 [PubMed - indexed for MEDLINE]Related articles

    17.

    Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs.

    McCarthy DM.

    Best Pract Res Clin Gastroenterol. 2001 Oct;15(5):755-73. Review.PMID: 11566039 [PubMed - indexed for MEDLINE]Related articles

    18.

    Evaluation of risk profiles for gastrointestinal and cardiovascular adverse effects in nonselective NSAID and COX-2 inhibitor users: a cohort study using pharmacy dispensing data in The Netherlands.

    Layton D, Souverein PC, Heerdink ER, Shakir SA, Egberts AC.

    Drug Saf. 2008;31(2):143-58.PMID: 18217790 [PubMed - indexed for MEDLINE]Related articles

    19.

    Proton-pump inhibitor therapy for acetylsalicylic acid associated upper gastrointestinal symptoms: a randomized placebo-controlled trial.

    Laheij RJ, Van Rossum LG, Jansen JB, Verheugt FW.

    Aliment Pharmacol Ther. 2003 Jul 1;18(1):109-15.PMID: 12848632 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Symptom-relieving effect of esomeprazole 40 mg daily in patients with heartburn.

    Johnsson F, Hatlebakk JG, Klintenberg AC, Román J.

    Scand J Gastroenterol. 2003 Apr;38(4):347-53.PMID: 12739705 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity

    You are here: NCBI > Literature > PubMed
    Write to the Help Desk